Literature DB >> 16013774

Factors changing the manifestation of pulmonary tuberculosis.

J Y Wang1, L N Lee, P R Hsueh.   

Abstract

OBJECTIVE: To investigate factors altering the manifestation and outcome of pulmonary tuberculosis (PTB).
DESIGN: The medical records of culture-proven TB patients from July 2001 through December 2002 were reviewed.
RESULTS: A total of 461 patients were identified. Diabetes (21.5%) and malignancy (15.2%) were the most common underlying comorbidities. Sixteen cancer patients were initially misdiagnosed as pulmonary metastasis or recurrence. Younger patients frequently had constitutional symptoms and haemoptysis, while older patients frequently had respiratory symptoms and pleural effusion. Male predominance was noted, except in the 21-40-year-old non-diabetic group. Diabetic patients were more likely to present with cavitary nodules. Lower lung field TB was noted in 96 (20.8%) patients, and was associated with female sex and consolidative pattern. Factors associated with poor prognosis included underlying malignancy, chronic renal failure, serum albumin <35 g/l, and need for intensive care.
CONCLUSION: Age influenced the manifestation of PTB. Diabetes mellitus was associated with a higher probability of cavitary nodules. TB should be considered in 21-40-year-old women with lower lung field consolidation. In cancer patients, pulmonary lesions should not be straightforwardly considered as metastasis or recurrence. The prognosis is poor for patients with underlying comorbidities, or in patients who need intensive

Entities:  

Mesh:

Year:  2005        PMID: 16013774

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  29 in total

Review 1.  Cavitary pulmonary disease.

Authors:  L Beth Gadkowski; Jason E Stout
Journal:  Clin Microbiol Rev       Date:  2008-04       Impact factor: 26.132

Review 2.  Tuberculosis and diabetes mellitus: convergence of two epidemics.

Authors:  Kelly E Dooley; Richard E Chaisson
Journal:  Lancet Infect Dis       Date:  2009-12       Impact factor: 25.071

3.  Empirical treatment with a fluoroquinolone delays the treatment for tuberculosis and is associated with a poor prognosis in endemic areas.

Authors:  J-Y Wang; P-R Hsueh; I-S Jan; L-N Lee; Y-S Liaw; P-C Yang; K-T Luh
Journal:  Thorax       Date:  2006-06-29       Impact factor: 9.139

Review 4.  Is there a connection between gestational diabetes mellitus, human immunodeficiency virus infection, and tuberculosis?

Authors:  M Alexander; A Gupta; J S Mathad
Journal:  Int J Tuberc Lung Dis       Date:  2019-01-01       Impact factor: 2.373

5.  The effect of diabetic control status on the clinical features of pulmonary tuberculosis.

Authors:  S W Park; J W Shin; J Y Kim; I W Park; B W Choi; J C Choi; Y S Kim
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-10-25       Impact factor: 3.267

Review 6.  Is there an effect of glucose lowering treatment on incidence and prognosis of tuberculosis? A systematic review.

Authors:  Marit Eika Jørgensen; Daniel Faurholt-Jepsen
Journal:  Curr Diab Rep       Date:  2014-07       Impact factor: 4.810

Review 7.  Tuberculosis and its incidence, special nature, and relationship with chronic obstructive pulmonary disease.

Authors:  Biswajit Chakrabarti; Peter M A Calverley; Peter D O Davies
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2007

8.  COPD and the risk of tuberculosis--a population-based cohort study.

Authors:  Malin Inghammar; Anders Ekbom; Gunnar Engström; Bengt Ljungberg; Victoria Romanus; Claes-Göran Löfdahl; Arne Egesten
Journal:  PLoS One       Date:  2010-04-13       Impact factor: 3.240

9.  Mycobacterial clearance from sputum is delayed during the first phase of treatment in patients with diabetes.

Authors:  Blanca I Restrepo; Susan P Fisher-Hoch; Brian Smith; Sangchoon Jeon; Mohammad H Rahbar; Joseph B McCormick
Journal:  Am J Trop Med Hyg       Date:  2008-10       Impact factor: 2.345

10.  Increased severity of tuberculosis in Guinea pigs with type 2 diabetes: a model of diabetes-tuberculosis comorbidity.

Authors:  Brendan K Podell; David F Ackart; Andres Obregon-Henao; Sarah P Eck; Marcela Henao-Tamayo; Michael Richardson; Ian M Orme; Diane J Ordway; Randall J Basaraba
Journal:  Am J Pathol       Date:  2014-01-31       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.